IgAN
12 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN) (NCT05125068) | Eledon Pharmaceuticals | 2022-03-21 |
| Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (NCT05097989) | Alexion Pharmaceuticals, Inc. | 2022-01-14 |
| Safety and Efficacy Study of VIS649 for IgA Nephropathy (NCT04287985) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2020-07-20 |
| Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 (NCT02682407) | Omeros Corporation | 2016-03-10 |
| Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment (NCT02523768) | Centre Hospitalier Universitaire de Saint Etienne | 2011-01-08 |
Track IgAN automatically
Every clearance here is in the API, with alerts when new ones post.